Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
10/2009
10/07/2009CN101548954A Sodium ferulate enteric preparation and preparation method
10/07/2009CN101548953A Medicine granule, preparation method thereof, and preparation containing same
10/07/2009CN101548951A Hydroxycamptothecin nano lipidosome for injections and method for preparing same
10/07/2009CN101548950A Tripterine nanometer lipid injection and method for preparing same
10/07/2009CN101548949A Paclitaxel nanoemulsion injection
10/07/2009CN101548947A Docetaxel nanometer lipid injection, preparation method and purpose thereof
10/07/2009CN101548946A Curcumin nano-lipid injection liquid, preparation method and application thereof
10/07/2009CN101548945A Long-acting flunixin meglumine injection and method for preparing same
10/07/2009CN100547004C Thioureido group-containing dendritic polymer and its preparing method and application
10/07/2009CN100546967C Method for preparing medicinal accessories sodium caprylate
10/07/2009CN100546658C Ligand of polyoxyethylene of containing target peptide toward to liver cancer and its synthesis method
10/07/2009CN100546656C Kidney-targeted medicine vector and the formed prodrug, preparation method and uses
10/07/2009CN100546655C Tablet composition containing Chinese orthodox medicine extract and process for producing the same
10/07/2009CN100546654C Use of chitosan quaternary ammonium salt/rectorite nano composite material
10/07/2009CN100546649C Ultrasonic microvesicle as immuno adjuvant and vaccine carrier
10/07/2009CN100546648C Transdermal botulinum toxin compositions
10/07/2009CN100546579C Nanometer microsphere of temozolomide polylactic acid and its preparation and preparing method therefor
10/07/2009CN100546572C Hydrochloride clindamycin palmitate soft capsule and the preparing method thereof
10/06/2009US7598341 Molecules that selectively home to vasculature of premalignant or malignant lesions of the pancreas and other organs
10/06/2009US7598338 Formed when exposed to base without requiring presence of second cross-linking reagent, redox catalyst, or radiation; for use as scaffolds in biological applications and tissue engineering
10/06/2009US7598294 Antiproliferative agents; antiinflammatory agents; anticancer agents; diagnosis, therapy
10/06/2009US7598246 A conjugated drug WITH ANTIBIOTIC, NUCLEOSIDE, ANTISENSE NUCLEIC ACID AND anti-cancer DRUGS CAPABLE OF RELEASING ANTIBIOTIC OR CYTOTOXIC COMPONENT UPON BINDING WITH BONE TISSUE; tissue-targeted therapy TREATING BONE CANCER AND INFECTION
10/06/2009US7598239 Side effect reduction; antiproliferative agents; schizophrenia
10/06/2009US7598235 Gonane ring substituted with hydroxy group and alkylamide derivatives used for achieving sustained systemic concentrations of therapeutic or prophylactic GABA(gamma-aminobutyric acid)analogs following administration to animals
10/06/2009US7598070 Excipients for use in adeno-associated virus pharmaceutical formulations, and pharmaceutical formulations made therewith
10/06/2009US7598056 Factor VII or VIIA-like molecules
10/06/2009US7597906 Apoptosis-mimicking synthetic entities and use thereof in medical treatment
10/06/2009US7597905 Hollow nanoparticle for use in the transfer of biopolymer into cells
10/06/2009US7597901 System for delivering a composition to the nasal membrane and method of using the same
10/06/2009US7597897 Medicinal compositions and method for the preparation thereof
10/06/2009US7597889 Recombinant polypeptides and nucleic acids; Graft-vs-host disease, host-vs-graft disease, organ transplant rejection, bone-marrow transplant rejection, autoimmune vasculitis, arthritis or asthma
10/06/2009US7597887 Graft-versus-host disease; inhibit secretion of Interferon-gamma (IFN-?) by lymphocytes or other immune cells in a mammal; inflammatory bowel disease is Crohn's disease, ulcerative colitis, or ileitis; KIM-1 (Kidney Injury Molecule-1)
10/06/2009US7597875 Diaminedioxime radiometal complexes
10/06/2009CA2442284C Biodegradable carrier and method for preparation thereof
10/06/2009CA2391430C Improved transdermal contraceptive delivery system and process
10/06/2009CA2378469C An oral solid composition comprising carbidopa, levodopa and entacapone
10/06/2009CA2376596C Humanized anti-erbb2 antibodies and treatment with anti-erbb2 antibodies
10/06/2009CA2329350C Topical formulation comprising poloxamers and further microbicides
10/06/2009CA2328076C Enhancement of antibody-cytokine fusion protein mediated immune responses by co-administration with angiogenesis inhibitor
10/06/2009CA2321116C Pharmaceutical formulation of a didemnin compound
10/06/2009CA2306224C Improved iodine antimicrobial compositions containing nonionic surfactants and halogen anions
10/01/2009WO2009121069A2 Compositions and methods for the preparation of nanoemulsions
10/01/2009WO2009121039A2 Administration of benzodiazepine compositions
10/01/2009WO2009121038A2 Shaped films of hydrogels fabricated using templates of patterned paper
10/01/2009WO2009120887A2 Compositions and methods for mediating rnai in vivo
10/01/2009WO2009120885A2 Stabilizing lipid compositions for oral pharmaceutical agents
10/01/2009WO2009120783A1 High affinity inhibitors of hepatitis c virus ns3/4a protease
10/01/2009WO2009120566A1 Improved topical ophthalmic compositions
10/01/2009WO2009120493A2 Stabilized compositions of alkylating agents and methods of using same
10/01/2009WO2009120358A1 Oligomer-nitrogenous base conjugates
10/01/2009WO2009120182A2 Sulfo-polymer powder and sulfo-polymer powder blends with carriers and/or actives
10/01/2009WO2009119836A1 Composition for external application comprising transcription factor decoy as active ingredient
10/01/2009WO2009119673A1 Transdermally absorbable preparation
10/01/2009WO2009119672A1 COMPOSITION FOR STABILIZING β-BLOCKER, AND TRANSDERMALLY ABSORBABLE PREPARATION COMPRISING THE COMPOSITION
10/01/2009WO2009119601A1 Water-based adhesive skin patch comprising ketoprofen lysine salt
10/01/2009WO2009119290A1 Oral preparation
10/01/2009WO2009118259A1 Ptph1 inhibitors for the treatment of alzheimer's disease
10/01/2009WO2009117804A1 An anti-cancer cytotoxic monoclonal antibody
10/01/2009WO2009100181A3 Absorbent ingestible agents and associated methods of manufacture and use
10/01/2009WO2009097508A3 Methods and compositions for wound healing
10/01/2009WO2009095479A3 Prodrug comprising a self-cleavable linker
10/01/2009WO2009092387A3 Pharmaceutical composition containing a garlic extract
10/01/2009WO2009092094A3 Method and device for repair of degenerative cartilage
10/01/2009WO2009049648A3 Improved pharmaceutical composition containing antiviral agent and method for the preparation thereof
10/01/2009US20090247778 Star polymer such as of a polylactone based on a central phosphorus atom derived from phosphorus oxychloride (POCl3) or ethyl dichlorophosphate; biodegradable and/or biocompatible; sustained release drug delivery; reverse thermal gelation
10/01/2009US20090247741 Process for the production of multiple cross-linked hyaluronic acid derivatives
10/01/2009US20090247738 Biocompatible poly-beta-1-4-n-acetylglucosamine
10/01/2009US20090247651 Bioadhesive Composition Formed Using Click Chemistry
10/01/2009US20090247648 Sebum absorption compositions
10/01/2009US20090247645 Stabilized compositions of alkylating agents and methods of using same
10/01/2009US20090247632 Dermatological compositions and methods
10/01/2009US20090247613 Chemically synthesized nucleic acid molecule with a pyrimidine modification; cancer, ocular disease, and other proliferative disorders; neovascularization, diabetic retinopathy, restenosis and polycystic kidney disease
10/01/2009US20090247608 Targeting Lipids
10/01/2009US20090247606 RNA Interference Mediated Inhibition of Adenosine A1 Receptor (ADORA1) Gene Expression Using Short Interfering Nucleic Acid (siNA)
10/01/2009US20090247580 Nitroxide radioprotector formulations and methods of use
10/01/2009US20090247529 Topical compositions
10/01/2009US20090247509 for treating central nervous system disorders such as psychological disorders, drug dependence and abuse, dyskinesia, dementia, anxiety disorders, sleep disorders and mood disorders
10/01/2009US20090247491 Composition comprising bisphosphonates for prevention and/or treatment of metabolic diseases of bones, process for preparing such composition and use thereof
10/01/2009US20090246854 Scleroprotein of an adeno-associated virus with modified chromatographic properties, the production thereof and use of the same
10/01/2009US20090246827 Recombinant toxin fragments
10/01/2009US20090246294 Pigment mixture, and use thereof in cosmetics, food and pharmaceuticals
10/01/2009US20090246288 Taste-masking oral dosage form and method of preparing the same
10/01/2009US20090246286 Particle for Medical Use and Process for Producing the Same
10/01/2009US20090246281 Soft steroid compositions for use in dry powder inhalers
10/01/2009US20090246277 Controlled release system
10/01/2009US20090246249 Coating compositions having improved performance
10/01/2009US20090246214 Fusion proteins containing recombinant cytotoxic rnases
10/01/2009US20090246211 Molecular constructs suitable for targeted conjugates
10/01/2009US20090246167 Stimuli-responsive systems for controlled drug delivery
10/01/2009US20090246159 Composition and Process for Treating Keratinous Substrates With At Least Two Immiscible Cosmetic Compositions
10/01/2009US20090246148 Medicinal aerosols and methods of delivery thereof
10/01/2009US20090246147 Delivery Of Antipsychotics Through An Inhalation Route
10/01/2009US20090246133 Methods and compositions related to internalizing rgd peptides
10/01/2009US20090246132 Epitope bound by MAbs A, B, C or D, where MAbs A, B, C and D have given variable domains; chimeric or humanized for side effect reduction; polymerase chain reaction
10/01/2009US20090246131 Production and Use of Novel Peptide-Based Agents for Use with Bi-Specific Antibodies
10/01/2009US20090246129 Compositions and methods for the diagnosis and treatment of tumor
10/01/2009CA2756690A1 Administration of benzodiazepine compositions
10/01/2009CA2719921A1 Orally-administered agent
10/01/2009CA2719803A1 Compositions and methods for the preparation of nanoemulsions
10/01/2009CA2719605A1 Transdermally absorbable preparation
1 ... 548 549 550 551 552 553 554 555 556 557 558 559 560 561 562 563 564 565 566 567 568 ... 1712